4//SEC Filing
KAY E GERALD 4
Accession 0001053310-21-000001
CIK 0001016504other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 10:52 AM ET
Size
5.7 KB
Accession
0001053310-21-000001
Insider Transaction Report
Form 4
KAY E GERALD
DirectorCEO and President10% Owner
Transactions
- Award
Stock Option (right to buy)
2021-11-03+65,000→ 65,000 totalExp: 2026-11-03→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission.
- [F2]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022.
Documents
Issuer
INTEGRATED BIOPHARMA INC
CIK 0001016504
Entity typeother
Related Parties
1- filerCIK 0001053310
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 10:52 AM ET
- Size
- 5.7 KB